Compare Intel Corp (INTC) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intel Corp vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Intel Corp trades at $106.12 (market cap $566.04B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.41 (market cap $25.27B). The key difference: Intel Corp is far larger — about 22.4× Royalty Pharma plc Class A Ordinary Shares's market cap, and Intel Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals — on Pluang, investors hold Intel Corp for 116 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| INTC | RPRX | |
|---|---|---|
Market Cap | $566.04B | $25.27B |
Volume | 118,475,837 | 3,671,183 |
Sector | Technology | Health |
52-Week High | $140.94 | $63.96 |
52-Week Low | $33.62 | $35.44 |
Typical Hold Time | 116 Days | 0 Days |
Enterprise Value | $586.85B | $32.50B |
Dividend Yield | 2.24% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intel (INTC) trades at $113.12, up 0.55% on the day, with a bullish technical signal supported by moving averages. Recent earnings beats and a 222% stock surge in 2026 reflect strong AI momentum and foundry growth, though negative net income and high valuation ratios signal caution. The company's cash flow improved in 2025, but competitive pressures and margin challenges persist.
The outlook hinges on Intel's foundry turnaround gaining traction, with revenue growth and external customer adoption as key catalysts. Risks include intense competition, high debt, and execution uncertainty. Analyst consensus is mixed, with a hold rating dominant, suggesting cautious optimism amid fundamental headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
